Trials / Completed
CompletedNCT01355016
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled MDT-637 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- MicroDose Therapeutx, Inc · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the range of single inhaled doses of a new dry powder product, MDT-637, that are safe and well-tolerated. This includes monitoring effects on pulmonary function and determination of blood levels of MDT-637 following inhalation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MDT-637 | Inhaled doses of MDT-637 over a 24 hour period |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2011-05-17
- Last updated
- 2012-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01355016. Inclusion in this directory is not an endorsement.